Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of two novel oral poliovirus type 2 vaccine candidates in previously vaccinated healthy adults
2018-001684-22Phase 2Completed
- Sponsor
- University of Antwerp
- Start
- May 2018
- Modality
- Vaccines & Immunotherapeutics, Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of nOPV2 candidate 1, novel oral poliovirus vaccine type 2 candidate 2 and sabin oral poliovirus vaccine type 2 in poliomyelitis (4 arms), sponsored by University of Antwerp. Primary endpoint: Safety. Started May 2018; status: completed.
02
Drugs
nOPV2 candidate 1novel oral poliovirus vaccine type 2 candidate 2sabin oral poliovirus vaccine type 2
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on 2018-001684-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001684-22.